Geode Capital Management, LLC Decibel Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$1.86 - $3.54 $7,756 - $14,761	4,170 Added 3.74%	115,567 $236,000
Q3 2022 Nov 14, 2022	BUY	$3.82 - $5.61 $155,069 - $227,732	40,594 Added 57.33%	111,397 $385,000
Q2 2022 Aug 12, 2022	BUY	$1.85 - $4.21 $2,812 - $6,399	1,520 Added 2.19%	70,803 $298,000
Q4 2021 Feb 11, 2022	SELL	$4.57 - $8.58 $1,247 - $2,342	-273 Reduced 0.39%	69,283 $322,000
Q3 2021 Nov 12, 2021	SELL	$6.6 - $9.04 $15,127 - $20,719	-2,292 Reduced 3.19%	69,556 $536,000
Q2 2021 Aug 13, 2021	SELL	$6.39 - $11.51 $243,433 - $438,484	-38,096 Reduced 34.65%	71,848 $617,000
Q1 2021 May 12, 2021	BUY	$10.56 - $19.9 $1.16 Million - $2.19 Million	109,944 New	109,944 $1.25 Million

Ticker DBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,964,500
Description
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.